Literature DB >> 24837983

Persistent neo-aortic growth during adulthood in patients after an arterial switch operation.

Teun van der Bom1, Roel L F van der Palen2, Berto J Bouma3, Sophie L van Veldhuisen3, Hubert W Vliegen4, Thelma C Konings5, Aeilko H Zwinderman6, Nico A Blom2, Dave R Koolbergen7, Mark G Hazekamp7, Barbara J M Mulder1.   

Abstract

OBJECTIVE: After the arterial switch operation (ASO), disproportional neo-aortic growth during childhood has been reported. Even though it has been suggested neo-aortic dilation will stabilise in adulthood, data are lacking. The aim of this study was to assess the change in neo-aortic dimensions, prevalence of neo-aortic dilation >40 mm and long-term outcome in adults who underwent ASO in childhood.
METHODS: All 116 ASO patients operated in a tertiary referral centre and born before 1995 were included. Of these, 83 (72%) survived to adulthood (>17 years) and six were lost to follow-up. Neo-aortic measurements performed in adulthood were collected from available echocardiographic, cardiovascular magnetic resonance and CT images. The time trend was analysed using a mixed model, adjusted for imaging modality.
RESULTS: Clinical data with at least one measurement of the neo-aortic diameter were available in 77 (93%) adult patients and serial measurements in 65 (78%). At baseline (median age 18.1 years), mean neo-aortic diameter was 36±5 mm. Mean neo-aortic growth was 0.31 mm/year (p<0.001 compared with normal value 0.08 mm/year) and was linear over time. Freedom from neo-aortic dilation beyond a diameter of 40 mm was 23% at 28 years of age. During a mean clinical follow-up in adulthood of 7.2 years (IQR 4.0 to 10.1), 3 (4%) patients underwent neo-aortic replacement. No other neo-aortic complications occurred.
CONCLUSIONS: In early adulthood, neo-aortic growth was on average linear and did not stabilise over time. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Aorta, Great Vessels and Trauma; Cardiac Surgery

Mesh:

Year:  2014        PMID: 24837983     DOI: 10.1136/heartjnl-2014-305702

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  Maladaptive aortic properties after the Norwood procedure: An angiographic analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial.

Authors:  Sarah T Plummer; Christoph P Hornik; Hamilton Baker; Gregory A Fleming; Susan Foerster; M Eric Ferguson; Andrew C Glatz; Russel Hirsch; Jeffrey P Jacobs; Kyong-Jin Lee; Alan B Lewis; Jennifer S Li; Mary Martin; Diego Porras; Wolfgang A K Radtke; John F Rhodes; Julie A Vincent; Jeffrey D Zampi; Kevin D Hill
Journal:  J Thorac Cardiovasc Surg       Date:  2016-04-14       Impact factor: 5.209

Review 2.  Aortic dilatation in complex congenital heart disease.

Authors:  Koichiro Niwa
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

Review 3.  Genetics of congenital heart disease: the contribution of the noncoding regulatory genome.

Authors:  Alex V Postma; Connie R Bezzina; Vincent M Christoffels
Journal:  J Hum Genet       Date:  2015-07-30       Impact factor: 3.172

4.  Transposition of the great arteries: Fetal pulmonary valve growth and postoperative neo-aortic root dilatation.

Authors:  Roel L F van der Palen; Carlijn van der Zee; Arja S Vink; Ingmar Knobbe; Sean J Jurgens; Elizabeth van Leeuwen; Caroline J Bax; Gideon J du Marchie Sarvaas; Nico A Blom; Monique C Haak; Caterina M Bilardo; Sally-Ann B Clur
Journal:  Prenat Diagn       Date:  2019-08-07       Impact factor: 3.050

5.  Progression of aortic root dilatation and aortic valve regurgitation after the arterial switch operation.

Authors:  Roel L F van der Palen; Teun van der Bom; Annika Dekker; Roula Tsonaka; Nan van Geloven; Irene M Kuipers; Thelma C Konings; Lukas A J Rammeloo; Arend D J Ten Harkel; Monique R M Jongbloed; Dave R Koolbergen; Barbara J M Mulder; Mark G Hazekamp; Nico A Blom
Journal:  Heart       Date:  2019-07-10       Impact factor: 5.994

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.